Publications by authors named "U V Ukah"
Objectives: We examined the ethnic origin of authors who published research articles in leading medical journals over the past 2 decades.
Study Design And Setting: We carried out a serial cross-sectional analysis of first and last authors who published original research articles in the British Medical Journal, Lancet, Journal of the American Medical Association, and New England Journal of Medicine in 2002, 2012, and 2022. The main outcome was the change in proportion of authors over time according to ethnic origin (Anglo, North/West European, South/West European, Asian, Arab and Middle Eastern, African), gender (male, female), and institutional affiliation in percentage points.
Objective: To investigate the risk of adverse neonatal events after a pregnancy complicated by severe maternal morbidity.
Study Design: We analyzed a population-based cohort of deliveries in Quebec, Canada, between 2006 and 2021. The main exposure measure was severe maternal morbidity, comprising life-threatening conditions such as severe hemorrhage, cardiac complications, and eclampsia.
Article Synopsis
- Severe maternal morbidity (SMM) can significantly affect a mother's long-term health, particularly her mental well-being, but little research has focused on this connection.
- This study investigates the impact of experiencing SMM during a first childbirth on the likelihood of subsequent hospitalizations or emergency visits for mental health issues over a 13-year period in Canada.
- Out of over 2 million postpartum individuals analyzed, 2.3% experienced SMM, and the results suggest a higher risk for mental health problems in those affected, taking into consideration various maternal demographics and health factors.
Introduction: The COVID-19 pandemic resulted in changes in prescription patterns and fillings for certain medications, but little is known about its impact on the dispensing of cardiovascular drugs.
Methods: Trends in dispensing of cardiovascular drugs before and during the pandemic were examined using a population-based cohort in Norway. Using interrupted time series analyses and considering March 1, 2020 as the interruption point, the impact of the pandemic on defined daily dose dispensing of prescribed cardiovascular drugs was estimated in a population of adults with and without pre-existing cardiovascular disease from January 2018 to December 2021.